121 related articles for article (PubMed ID: 18471075)
1. Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approach.
Piper DR; Duff SR; Eliason HC; Frazee WJ; Frey EA; Fuerstenau-Sharp M; Jachec C; Marks BD; Pollok BA; Shekhani MS; Thompson DV; Whitney P; Vogel KW; Hess SD
Assay Drug Dev Technol; 2008 Apr; 6(2):213-23. PubMed ID: 18471075
[TBL] [Abstract][Full Text] [Related]
2. Early evaluation of compound QT prolongation effects: a predictive 384-well fluorescence polarization binding assay for measuring hERG blockade.
Deacon M; Singleton D; Szalkai N; Pasieczny R; Peacock C; Price D; Boyd J; Boyd H; Steidl-Nichols JV; Williams C
J Pharmacol Toxicol Methods; 2007; 55(3):238-47. PubMed ID: 17141530
[TBL] [Abstract][Full Text] [Related]
3. Improved throughput of PatchXpress hERG assay using intracellular potassium fluoride.
Zeng H; Penniman JR; Kinose F; Kim D; Trepakova ES; Malik MG; Dech SJ; Balasubramanian B; Salata JJ
Assay Drug Dev Technol; 2008 Apr; 6(2):235-41. PubMed ID: 18471077
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel.
Murphy SM; Palmer M; Poole MF; Padegimas L; Hunady K; Danzig J; Gill S; Gill R; Ting A; Sherf B; Brunden K; Stricker-Krongrad A
J Pharmacol Toxicol Methods; 2006; 54(1):42-55. PubMed ID: 16326118
[TBL] [Abstract][Full Text] [Related]
5. Fluorescently labeled analogues of dofetilide as high-affinity fluorescence polarization ligands for the human ether-a-go-go-related gene (hERG) channel.
Singleton DH; Boyd H; Steidl-Nichols JV; Deacon M; Groot MJ; Price D; Nettleton DO; Wallace NK; Troutman MD; Williams C; Boyd JG
J Med Chem; 2007 Jun; 50(13):2931-41. PubMed ID: 17536794
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human Ether-à-go-go related gene screening assays based on IonWorks Quattro and thallium flux.
Bridal TR; Margulis M; Wang X; Donio M; Sorota S
Assay Drug Dev Technol; 2010 Dec; 8(6):755-65. PubMed ID: 20658944
[TBL] [Abstract][Full Text] [Related]
7. A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel.
Titus SA; Beacham D; Shahane SA; Southall N; Xia M; Huang R; Hooten E; Zhao Y; Shou L; Austin CP; Zheng W
Anal Biochem; 2009 Nov; 394(1):30-8. PubMed ID: 19583963
[TBL] [Abstract][Full Text] [Related]
8. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.
Guo L; Guthrie H
J Pharmacol Toxicol Methods; 2005; 52(1):123-35. PubMed ID: 15936217
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic membrane platform containing hERG potassium channel and its application to drug screening.
Arslan Yildiz A; Kang C; Sinner EK
Analyst; 2013 Apr; 138(7):2007-12. PubMed ID: 23423263
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the rubidium efflux assay for preclinical identification of HERG blockade.
Chaudhary KW; O'Neal JM; Mo ZL; Fermini B; Gallavan RH; Bahinski A
Assay Drug Dev Technol; 2006 Feb; 4(1):73-82. PubMed ID: 16506891
[TBL] [Abstract][Full Text] [Related]
11. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
12. Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.
Huang XP; Mangano T; Hufeisen S; Setola V; Roth BL
Assay Drug Dev Technol; 2010 Dec; 8(6):727-42. PubMed ID: 21158687
[TBL] [Abstract][Full Text] [Related]
13. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.
Bridgland-Taylor MH; Hargreaves AC; Easter A; Orme A; Henthorn DC; Ding M; Davis AM; Small BG; Heapy CG; Abi-Gerges N; Persson F; Jacobson I; Sullivan M; Albertson N; Hammond TG; Sullivan E; Valentin JP; Pollard CE
J Pharmacol Toxicol Methods; 2006; 54(2):189-99. PubMed ID: 16563806
[TBL] [Abstract][Full Text] [Related]
14. hERG potency estimates based upon dose solution analysis: What have we learned?
Qu Y; Schnier P; Zanon R; Vargas HM
J Pharmacol Toxicol Methods; 2011; 64(3):251-7. PubMed ID: 21888984
[TBL] [Abstract][Full Text] [Related]
15. Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels.
Chiu PJ; Marcoe KF; Bounds SE; Lin CH; Feng JJ; Lin A; Cheng FC; Crumb WJ; Mitchell R
J Pharmacol Sci; 2004 Jul; 95(3):311-9. PubMed ID: 15272206
[TBL] [Abstract][Full Text] [Related]
16. Whole-cell configuration of the patch-clamp technique in the hERG channel assay to predict the ability of a compound to prolong QT interval.
Goineau S; Legrand C; Froget G
Curr Protoc Pharmacol; 2012 Jun; Chapter 10():Unit 10.15.. PubMed ID: 22684720
[TBL] [Abstract][Full Text] [Related]
17. A structure-based computational workflow to predict liability and binding modes of small molecules to hERG.
Kalyaanamoorthy S; Lamothe SM; Hou X; Moon TC; Kurata HT; Houghton M; Barakat KH
Sci Rep; 2020 Oct; 10(1):16262. PubMed ID: 33004839
[TBL] [Abstract][Full Text] [Related]
18. A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity.
Anwar-Mohamed A; Barakat KH; Bhat R; Noskov SY; Tyrrell DL; Tuszynski JA; Houghton M
Toxicol Lett; 2014 Nov; 230(3):382-92. PubMed ID: 25127758
[TBL] [Abstract][Full Text] [Related]
19. Fluorogenic probe for the human Ether-a-Go-Go-Related Gene potassium channel imaging.
Liu Z; Wang B; Ma Z; Zhou Y; Du L; Li M
Anal Chem; 2015 Mar; 87(5):2550-4. PubMed ID: 25665091
[TBL] [Abstract][Full Text] [Related]
20. Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-à-go-go-related gene channels.
Perrin MJ; Kuchel PW; Campbell TJ; Vandenberg JI
Mol Pharmacol; 2008 Nov; 74(5):1443-52. PubMed ID: 18701618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
